Search Results - Yawen Sheng

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-β1/Smad2/3 pathway.

    Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-β1/Smad2/3 pathway. by XiaoLin Sun, Yawen Sheng, Pei Xu, Qian Peng, Zhongbao Ruan

    Published 2025-01-01

    Atrial fibrillation (AF) and heart failure (HF) are mutually reinforcing, and the prognosis for both diseases is poor. Vericiguat is the first oral soluble guanylate cyclase (sGC) stimulator to be approved for the treatment of symptomatic, ejection fraction-reduced chronic heart failure (HFrEF) in a...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: